Facebook to BAN claims about ‘man-made’ Covid-19 & ‘unsafe’ vaccines as it launches election-like campaign to promote vaccination

Facebook is expanding the list of ‘false’ and ‘debunked’ claims about the coronavirus and vaccines that will be grounds for banning from the platform, while launching the largest ‘authoritative’ vaccination campaign worldwide.

Under the Community Standards policy, posts with “debunked claims” that Covid-19 is “man-made or manufactured,” or that vaccines are ineffective, unsafe, dangerous or cause autism will be removed starting Monday, VP of Integrity Guy Rosen announced on the Facebook blog.

The new policy was implemented following consultations with the World Health Organization (WHO) and others, and will help Facebook “continue to take aggressive action against misinformation” about Covid-19 and vaccines, Rosen added.

Even if they don’t violate any of the listed policies, posts about Covid-19 or vaccines will still be subject to review by “third-party fact-checkers” and labeled and “demoted” if rated false.

Keep reading

CDC: Over 500 Deaths Now Following MRNA Experimental Injections

The CDC has done another data dump into the Vaccine Adverse Event Reporting System (VAERS), a U.S. Government funded database that tracks injuries and deaths caused by vaccines.

The data goes through January 29, 2021, with 11,249 recorded adverse events, including 501 deaths following injections of the experimental COVID mRNA shots by Pfizer and Moderna.

Keep reading

Norway May Refine Vaccine Strategy After Elderly Deaths, PM Says

The Prime Minister of Norway, Erna Solberg, says her country may fine-tune the vaccination of its oldest, sickest citizens as it tries to make sense of a recent spate of deaths.

Having weathered the pandemic better than most, Norway suddenly made international headlines this month after revealing that more than 30 people — all over 70 and all already sick — died not long after being vaccinated against Covid-19. Solberg says the intense global interest in the news was “exaggerated” as she tries to ensure the development doesn’t put people off inoculation.

“We don’t believe there’s any problem with the safety of the vaccines,” Solberg said in an interview with Bloomberg Live that aired on Tuesday. “But we will maybe not give them to the most vulnerable of the elderly, because that might speed up a process where they were what we would say at the end of life phase anyway,” so, “that probably is not what we will continue to do.”

Keep reading

39-year-old nurse aide dies ‘within 48 hours’ of receiving mandated COVID-19 shot

A 39-year-old woman with no known comorbidities died unexpectedly in northern Ohio within 48 hours of receiving a COVID-19 vaccine, which was reportedly required by her employer.

Janet L. Moore, a nurse aide at Admirals Pointe Nursing Home (APNH) in Huron, was found unresponsive in her car outside her apartment complex on December 31 around 8:00 p.m., her brother Jacob Gregory told LifeSiteNews.

“She was coming home from work and as soon as she drove into her parking lot she passed away,” he said. “According to her neighbors she wasn’t feeling good directly after the vaccine, and then ever since the vaccine she was actually feeling nauseated, she’d have like migraines and stuff like that. And then, within 48 hours, she ended up passing away.”

When asked if he knew the brand of the vaccine, Gregory, who lives in Akron, said, “According to my brother, it was by Pfizer, but I’m not absolutely sure on that.”

Keep reading

Pfizer wants India to order COVID-19 vaccine before pursuing approval

Pfizer was the first company to seek emergency-use authorisation (EUA) for a COVID-19 vaccine in India, but the government this month approved two much cheaper shots – one from Oxford University/AstraZeneca and another developed at home by Bharat Biotech with the Indian Council of Medical Research.

India’s Central Drugs Standard Control Organisation (CDSCO) says Pfizer officials failed to turn up to meetings after the company’s application was made in early December. The regulator has also declined to accept the company’s request for approval without a small local trial on the vaccine’s safety and immunogenicity for Indians, Reuters has reported.

Keep reading